| | |
| | |
| Clinical data | |
|---|---|
| Trade names | Somelin (JP) |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H14BrFN2O2 |
| Molar mass | 377.213 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Haloxazolam (marketed in Japan under the brand name Somelin), is a drug which is a benzodiazepine derivative. [2] [3] [4] It has similar hypnotic properties as the benzodiazepine drugs triazolam, temazepam, and flunitrazepam and as such is indicated for the treatment of insomnia. [5] A study in cats comparing estazolam and haloxazolam found that haloxazolam only affects gamma motor neurons, whereas estazolam affects both alpha and gamma motor neurons. [6]